Your browser doesn't support javascript.
loading
The Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19.
Ambrose, Nalini; Amin, Alpesh; Anderson, Brian; Bertagnolli, Monica; Campion, Francis; Chow, Dan; Danan, Risa; D'Arinzo, Lauren; Drews, Ashley; Erlandson, Karl; Fitzgerald, Kristin; Gaspar, Fraser; Gong, Carlene; Hanna, George; Hawley, Heather; Jones, Stephen; Lopansri, Bert; Mullen, Ty; Musser, James; O'Horo, John; Piantadosi, Steven; Pritt, Bobbi; Razonable, Raymund; Rele, Shyam; Roberts, Seth; Sandmeyer, Suzanne; Stein, David; Te, Jerez; Vahidy, Farhaan; Webb, Brandon; Welch, Nathan; Wood, Alexander; Yttri, Jennifer.
  • Ambrose N; The MITRE Corporation, Bedford, MA, USA.
  • Amin A; Department of Medicine, University of California, Irvine, CA, USA.
  • Anderson B; Hospital Medicine Program, University of California, Irvine, CA, USA.
  • Bertagnolli M; The MITRE Corporation, Bedford, MA, USA.
  • Campion F; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Chow D; The MITRE Corporation, Bedford, MA, USA. fcampion@mitre.org.
  • Danan R; Department of Population Medicine, Harvard Medical School, Boston, MA, USA. fcampion@mitre.org.
  • D'Arinzo L; Department of Radiological Sciences, University of California, Irvine, CA, USA.
  • Drews A; The MITRE Corporation, Bedford, MA, USA.
  • Erlandson K; The MITRE Corporation, Bedford, MA, USA.
  • Fitzgerald K; Division of Infectious Diseases, Department of Medicine, Houston Methodist, Houston, TX, USA.
  • Gaspar F; Houston Methodist Academic Institute, Houston, TX, USA.
  • Gong C; Weill Cornell Medical College, New York, NY, USA.
  • Hanna G; Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response, US Department of Health and Human Services, Washington, DC, USA.
  • Hawley H; The MITRE Corporation, Bedford, MA, USA.
  • Jones S; The MITRE Corporation, Bedford, MA, USA.
  • Lopansri B; Booz Allen Hamilton in Support of BARDA, Washington, DC, USA.
  • Mullen T; Tunnell Government Services in Support of BARDA, Princeton, NJ, USA.
  • Musser J; The MITRE Corporation, Bedford, MA, USA.
  • O'Horo J; Center for Health Data Science and Analytics, Houston Methodist, Houston, TX, USA.
  • Piantadosi S; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Murray, UT, USA.
  • Pritt B; Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Razonable R; The MITRE Corporation, Bedford, MA, USA.
  • Rele S; Laboratory of Molecular and Translational Human Infectious Disease Research, Center for Infectious Diseases, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute and Houston Methodist Hospital, Houston, TX, USA.
  • Roberts S; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Sandmeyer S; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY, USA.
  • Stein D; Center for Individualized Medicine-Mayo Clinic Research, Rochester, MN, USA.
  • Te J; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Vahidy F; Center for Individualized Medicine-Mayo Clinic Research, Rochester, MN, USA.
  • Webb B; Center for Individualized Medicine-Mayo Clinic Research, Rochester, MN, USA.
  • Welch N; The MITRE Corporation, Bedford, MA, USA.
  • Wood A; Shabas Solutions LLC in Support of BARDA, Fairfax, VA, USA.
  • Yttri J; The MITRE Corporation, Bedford, MA, USA.
J Gen Intern Med ; 38(16): 3472-3481, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37715096

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2023 Tipo del documento: Article